|
T2148 |
Carbidopa monohydrate
|
Carbidopa Hydrate,S(-)-Carbidopa |
Decarboxylase
,
Aryl Hydrocarbon Receptor
|
|
Carbidopa monohydrate (S(-)-Carbidopa) is an inhibitor of DOPA decarboxylase, preventing the conversion of levodopa to dopamine. |
|
T68937 |
Carbidopa hydrochloride
|
|
|
|
Carbidopa hydrochloride is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa. This property is significant in that it allows a greater proportion of peripheral levodopa... |
|
T15339 |
Foscarbidopa
|
Carbidopa 4′-monophosphate |
Dopamine Receptor
|
|
Foscarbidopa is a prodrug of Carbidopa. It acts as a dopamine receptor agonist. |
|
T1119 |
Rasagiline
|
AGN1135,TVP1012 |
BCL
,
MAO
,
Monoamine Oxidase
|
|
Rasagiline (AGN1135) is an inhibitor of monamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinsons disease. |
|
T6708 |
Tolcapone
|
Tasmar,Ro 40-7592 |
Apoptosis
,
Beta Amyloid
,
Transferase
|
|
Tolcapone (Ro 40-7592) is a catechol-O-methyltransferase inhibitor used in the therapy of Parkinson disease as adjunctive therapy in combination with levodopa and carbidopa. |
|
TMIH-0576 |
Tolcapone-d7
|
|
|
|
Tolcapone-d7 is a deuterated compound of Tolcapone. Tolcapone has a CAS number of 134308-13-7. Tolcapone is a catechol-O-methyltransferase inhibitor used in the therapy of Parkinson disease as adjunctive therapy in combi... |
